184 related articles for article (PubMed ID: 28042660)
1. Determination of minimum biofilm eradication concentrations of orbifloxacin for canine bacterial uropathogens over different treatment periods.
Shimizu T; Harada K
Microbiol Immunol; 2017 Jan; 61(1):17-22. PubMed ID: 28042660
[TBL] [Abstract][Full Text] [Related]
2. Assessment of urinary pharmacokinetics and pharmacodynamics of orbifloxacin in healthy dogs with ex vivo modelling.
Shimizu T; Harada K; Manabe S; Tsukamoto T; Ito N; Hikasa Y
J Med Microbiol; 2017 May; 66(5):616-621. PubMed ID: 28470147
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of difloxacin against canine bacterial isolates.
van den Hoven R; Wagenaar JA; Walker RD
J Vet Diagn Invest; 2000 May; 12(3):218-23. PubMed ID: 10826834
[TBL] [Abstract][Full Text] [Related]
4. Mutant prevention concentration of orbifloxacin: comparison between Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus pseudintermedius of canine origin.
Shimizu T; Harada K; Kataoka Y
Acta Vet Scand; 2013 May; 55(1):37. PubMed ID: 23634902
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility survey on bacterial agents of canine and feline urinary tract infections: Weight of the empirical treatment.
Rampacci E; Bottinelli M; Stefanetti V; Hyatt DR; Sgariglia E; Coletti M; Passamonti F
J Glob Antimicrob Resist; 2018 Jun; 13():192-196. PubMed ID: 29408407
[TBL] [Abstract][Full Text] [Related]
6. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
Saini H; Chhibber S; Harjai K
Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive phenotypic and genotypic characterization and comparison of virulence, biofilm, and antimicrobial resistance in urinary Escherichia coli isolated from canines.
Gilbertie JM; Levent G; Norman KN; Vinasco J; Scott HM; Jacob ME
Vet Microbiol; 2020 Oct; 249():108822. PubMed ID: 32937249
[TBL] [Abstract][Full Text] [Related]
8. Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats.
Boothe DM; Boeckh A; Simpson RB; Dubose K
J Vet Intern Med; 2006; 20(6):1297-306. PubMed ID: 17186841
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial naphthoquinone derivatives targeting resistant strain Gram-negative bacteria in biofilms.
Novais JS; Moreira CS; Silva ACJA; Loureiro RS; Sá Figueiredo AM; Ferreira VF; Castro HC; da Rocha DR
Microb Pathog; 2018 May; 118():105-114. PubMed ID: 29550501
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance of bacterial pathogens isolated from canine urinary tract infections.
Yu Z; Wang Y; Chen Y; Huang M; Wang Y; Shen Z; Xia Z; Li G
Vet Microbiol; 2020 Feb; 241():108540. PubMed ID: 31928695
[TBL] [Abstract][Full Text] [Related]
11. Biocide Exposure Induces Changes in Susceptibility, Pathogenicity, and Biofilm Formation in Uropathogenic
Henly EL; Dowling JAR; Maingay JB; Lacey MM; Smith TJ; Forbes S
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642923
[TBL] [Abstract][Full Text] [Related]
12. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M
Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Proteus mirabilis distribution in multi-species biofilms on urinary catheters and determination of bacteria resistance to antimicrobial agents.
Moryl M; Torzewska A; Jałmuzna P; Rózalski A
Pol J Microbiol; 2013; 62(4):377-84. PubMed ID: 24730132
[TBL] [Abstract][Full Text] [Related]
14. Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro.
Brothers AM; Gibbs PS; Wooley RE
Vet Ther; 2002; 3(4):493-500. PubMed ID: 12584687
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of biofilm production by Pseudomonas aeruginosa from canine ears and the impact of biofilm on antimicrobial susceptibility in vitro.
Pye CC; Yu AA; Weese JS
Vet Dermatol; 2013 Aug; 24(4):446-9, e98-9. PubMed ID: 23738965
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic susceptibility of bacteria isolated from infections in cats and dogs throughout Europe (2002-2009).
Kroemer S; El Garch F; Galland D; Petit JL; Woehrle F; Boulouis HJ
Comp Immunol Microbiol Infect Dis; 2014 Mar; 37(2):97-108. PubMed ID: 24447508
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Susceptibility Monitoring of Bacterial Pathogens Isolated from Urinary Tract Infections in Dogs and Cats Across Europe: ComPath Results.
Moyaert H; Morrissey I; de Jong A; El Garch F; Klein U; Ludwig C; Thiry J; Youala M
Microb Drug Resist; 2017 Apr; 23(3):391-403. PubMed ID: 28384093
[TBL] [Abstract][Full Text] [Related]
18. Application of Novel 3,4-Dihydroxyphenylalanine-Containing Antimicrobial Polymers for the Prevention of Uropathogen Attachment to Urinary Biomaterials.
MacPhee RA; Koepsel J; Tailly T; Vangala SK; Brennan L; Cadieux PA; Burton JP; Wattengel C; Razvi H; Dalsin J
J Endourol; 2019 Jul; 33(7):590-597. PubMed ID: 31140304
[No Abstract] [Full Text] [Related]
19. Susceptibility of canine and feline bacterial pathogens to pradofloxacin and comparison with other fluoroquinolones approved for companion animals.
Schink AK; Kadlec K; Hauschild T; Brenner Michael G; Dörner JC; Ludwig C; Werckenthin C; Hehnen HR; Stephan B; Schwarz S
Vet Microbiol; 2013 Feb; 162(1):119-26. PubMed ID: 22939523
[TBL] [Abstract][Full Text] [Related]
20. Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005).
Rock W; Colodner R; Chazan B; Elias M; Raz R
Isr Med Assoc J; 2007 Nov; 9(11):803-5. PubMed ID: 18085038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
